BioSpace News Archive

Biotech Beach

Dollar Tree Takes Important Step Toward Addressing Toxic Chemicals In Products, Reports Campaign for Healthier Solutions

After Years of Pressure, Environmental Justice Organizations Celebrate Progress but Warn Dollar Store is Still Short of Protective Policies

May 6, 2019
·
2 min read
Innovation Tour on Medical Design and Manufacturing; Medtec China 2019 Visitor Registration Initiated

The 15th Exhibition of Medical Device Design & Manufacturing in China will be held from September 25–27 in Shanghai.

May 6, 2019
·
3 min read
Policy

Focus on the bleak ramifications of falling fertility rates in South East Asian countries

The deeper implications of falling fertility rates in South East Asia, particularly China and Japan, have been brought into sharp focus at a global conference on human reproduction in Hong Kong.

May 6, 2019
·
3 min read
A Sneak Peek at the 6th Nutraceutical Industry Development Conference under the Background of Thriving Overseas Health Products - May 6, 2019

President Xi of China has recently emphasized in a speech that openness and cooperation are a major driving force behind dynamic international economic and trade activities.

May 6, 2019
·
3 min read
Drug Development

With FDA Target Action Date this Month for Zolgensma, AveXis Releases Even More Positive Data

SMA is a severe neuromuscular disease caused by a mutation in the SMN1 gene, which codes for SMN, a protein necessary for motor neuron function.

May 6, 2019
·
3 min read
·
Mark Terry
Drug Development

Cytokinetics’ ALS Treatment Fails to Hit Endpoints in Phase II, Company Notes Several Positive Results

Despite not hitting endpoints, Cytokinetics noted that the FORTITUDE-ALS trial demonstrated consistency of effect for doses, endpoints and timepoints.

May 6, 2019
·
3 min read
·
Alex Keown
Drug Development

Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms

San Diego-based Neurocrine Biosciences presented data from two Phase III clinical trials of opicapone, a once-daily, oral catechol-O-methyltransferase (COMT) inhibitor for Parkinson’s disease.

May 6, 2019
·
3 min read
·
Mark Terry
Deals

Lundbeck Acquires Abide Therapeutics for $250M, Gains San Diego Discovery Site

With a $250 million cash down payment, Denmark’s H. Lundbeck A/S snapped up San Diego-based Abide Therapeutics to gain a novel discovery platform and a U.S.-based research hub.

May 6, 2019
·
2 min read
·
Alex Keown
FDA

Pfizer’s Tafamidis Approved in First for Rare Heart Disease

The approval is a first for the the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM). The drug has a list price of $225,000.

May 6, 2019
·
3 min read
·
Alex Keown
Bio NC

Your Feedback Matters! The Right Opportunity

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your ‘right opportunity’ to consider a new job.

May 6, 2019
·
1 min read
·
Editorial Staff